BLB&B Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $464K | Buy |
5,126
+21
| +0.4% | +$1.76K | 0.02% | 191 |
|
|
2026
Q1 | $409K | Sell |
5,105
-44
| -0.9% | -$3.63K | 0.02% | 198 |
|
|
2025
Q4 | $439K | Sell |
5,149
-5
| -0.1% | -$410 | 0.02% | 198 |
|
|
2025
Q3 | $401K | Buy |
5,154
+623
| +14% | +$48.7K | 0.02% | 200 |
|
|
2025
Q2 | $354K | Sell |
4,531
-28
| -0.6% | -$2.09K | 0.02% | 208 |
|
|
2025
Q1 | $330K | Buy |
4,559
+400
| +10% | +$28.6K | 0.02% | 217 |
|
|
2024
Q4 | $308K | Sell |
4,159
-361
| -8% | -$25.3K | 0.02% | 223 |
|
|
2024
Q3 | $298K | Buy |
4,520
+400
| +10% | +$29.1K | 0.02% | 230 |
|
|
2024
Q2 | $381K | Hold |
4,120
| – | – | 0.02% | 198 |
|
|
2024
Q1 | $394K | Hold |
4,120
| – | – | 0.02% | 201 |
|
|
2023
Q4 | $314K | Hold |
4,120
| – | – | 0.02% | 206 |
|
|
2023
Q3 | $285K | Hold |
4,120
| – | – | 0.02% | 198 |
|
|
2023
Q2 | $389K | Sell |
4,120
-527
| -11% | -$45.8K | 0.03% | 177 |
|
|
2023
Q1 | $384K | Sell |
4,647
-796
| -15% | -$62.6K | 0.03% | 168 |
|
|
2022
Q4 | $406K | Hold |
5,443
| – | – | 0.03% | 171 |
|
|
2022
Q3 | $450K | Hold |
5,443
| – | – | 0.04% | 156 |
|
|
2022
Q2 | $518K | Hold |
5,443
| – | – | 0.04% | 151 |
|
|
2022
Q1 | $641K | Buy |
5,443
+53
| +1% | +$5.95K | 0.04% | 144 |
|
|
2021
Q4 | $698K | Sell |
5,390
-170
| -3% | -$19.8K | 0.05% | 145 |
|
|
2021
Q3 | $629K | Hold |
5,560
| – | – | 0.04% | 161 |
|
|
2021
Q2 | $576K | Hold |
5,560
| – | – | 0.04% | 160 |
|
|
2021
Q1 | $465K | Sell |
5,560
-320
| -5% | -$27.1K | 0.04% | 171 |
|
|
2020
Q4 | $536K | Buy |
5,880
+720
| +14% | +$59.7K | 0.04% | 165 |
|
|
2020
Q3 | $412K | Hold |
5,160
| – | – | 0.04% | 170 |
|
|
2020
Q2 | $357K | Hold |
5,160
| – | – | 0.04% | 188 |
|
|
2020
Q1 | $324K | Hold |
5,160
| – | – | 0.04% | 194 |
|
|
2019
Q4 | $401K | Hold |
5,160
| – | – | 0.04% | 198 |
|
|
2019
Q3 | $378K | Buy |
5,160
+480
| +10% | +$33.7K | 0.04% | 203 |
|
|
2019
Q2 | $288K | Hold |
4,680
| – | – | 0.03% | 229 |
|
|
2019
Q1 | $298K | Hold |
4,680
| – | – | 0.04% | 227 |
|
|
2018
Q4 | $239K | Hold |
4,680
| – | – | 0.03% | 244 |
|
|
2018
Q3 | $272K | Hold |
4,680
| – | – | 0.03% | 253 |
|
|
2018
Q2 | $227K | Sell |
4,680
-1,800
| -28% | -$84K | 0.03% | 270 |
|
|
2018
Q1 | $301K | Hold |
6,480
| – | – | 0.04% | 241 |
|
|
2017
Q4 | $243K | Hold |
6,480
| – | – | 0.03% | 258 |
|
|
2017
Q3 | $236K | Hold |
6,480
| – | – | 0.04% | 262 |
|
|
2017
Q2 | $255K | Hold |
6,480
| – | – | 0.04% | 243 |
|
|
2017
Q1 | $203K | Hold |
6,480
| – | – | 0.03% | 267 |
|
|
2016
Q4 | $202K | Hold |
6,480
| – | – | 0.04% | 273 |
|
|
2016
Q3 | $260K | Hold |
6,480
| – | – | 0.05% | 240 |
|
|
2016
Q2 | $215K | Buy |
+6,480
| New | +$222K | 0.04% | 247 |
|
Other funds holding EW
BLB&B Advisors's EW Position: Q2 2026 in Review
BLB&B Advisors increased its Edwards Lifesciences (EW) stake by 0.41% in Q2 2026, buying an estimated $1.76K and bringing the position to 5,126 shares worth $464K. The position accounts for 0.02% of the portfolio, ranked #191.
BLB&B Advisors first reported a position in EW in Q2 2016 and has held it in 41 quarters since. The position peaked at $698K in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- BLB&B Advisors held 5,126 shares of Edwards Lifesciences worth $464K as of Q2 2026.
- BLB&B Advisors bought 21 Edwards Lifesciences shares in Q2 2026, an estimated $1.76K.
- Edwards Lifesciences made up 0.02% of BLB&B Advisors's portfolio in Q2 2026, its #191 holding.
- BLB&B Advisors first reported a position in Edwards Lifesciences in Q2 2016 and has held it in 41 quarters since.
- BLB&B Advisors's Edwards Lifesciences position peaked at $698K in Q4 2021.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on BLB&B Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.